Chem. J. Chinese Universities ›› 2022, Vol. 43 ›› Issue (12): 20220430.doi: 10.7503/cjcu20220430

• Review • Previous Articles     Next Articles

Research Progress of Organic Small Molecule Theranostic Probes Integrating Fluorescence Imaging and Chemotherapy

CHANG Tonghang1,3, CHENG Zhen1,2,3()   

  1. 1.State Key Laboratory of Drug Research,Molecular Imaging Center,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China
    2.Shandong Laboratory of Yantai Drug Discovery,Bohai Rim Advanced Research Institute for Drug Discovery,Yantai 264117,China
    3.University of Chinese Academy of Sciences,Beijing 100049,China
  • Received:2022-06-17 Online:2022-12-10 Published:2022-07-19
  • Contact: CHENG Zhen E-mail:zcheng@simm.ac.cn
  • Supported by:
    the Shanghai Municipal Science and Technology Major Project, China

Abstract:

Combining diagnostic and therapeutic functions is an emerging strategy to treat diseases such as cancer. As a promising novel medical regimen, the integration of diagnosis and treatment has potential functions in rapidly obtaining in vivo information, improving biodistribution, reducing dosage, and reducing toxic and side effects. Especially, fluorescence imaging has been widely used in pre-clinical and clinical medical research. In recent years, near-infrared fluorescence imaging has progressed rapidly with improved penetration depth and imaging resolution for in vivo imaging. In this review, we summarized some recent researches on single-molecule based theranostic agents integrating fluorescence imaging and chemotherapy, and foresaw future research on theranostic probes.

Key words: Theranostic probe, Near infrared fluorescence imaging, Chemotherapy

CLC Number: 

TrendMD: